Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for B Raf
Most Correlated Studies
- Melanoma with WT and mutant B-RAF and N-RAS
- Lung cancer induced by c-Raf and associated gene expression profiles in transgenic mice
- Multiple myeloma INA-6 cells treated with pan-RAF1 inhibitor SB-590885 or MEK1 inhibitor PD-325901
- Hepatitis B and C virus infected liver tissue from cancerous and noncancerous regions.
- Antitumor efficacy of GDC-0879 involving BRAF mutational status
Most Relevant Literature
- Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
- Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.
- Computational analysis of natural product B-Raf inhibitors.
- Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor.
- A novel BRAF::PTPRN2 fusion in meningioma: a case report.
Most Relevant Clinical Trials
- Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease
- Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF M…
- Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot S…
- Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preop…
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorect…
